FDA Approves Journavx Drug to Treat Pain Without Addiction Risk

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.

Visit Direct Link

You Might Also Like

Post comment